The last sentence about its basis being a little more solid than Biotron. That's the thing about this company, the technology is tangible and so far effective.
Ann: First Patients Complete Nerve Regeneration Trial, page-537
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.030(8.11%) |
Mkt cap ! $83.73M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.5¢ | 38.5¢ | $284.0K | 720.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22248 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 208719 | 7 |
View Market Depth
| Last trade - 15.58pm 11/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |